These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2894873

  • 1. Effect of dopamine antagonists on the urine flow of rats infused with hypotonic saline.
    Angchanpen P, Marin-Grez M, Schnermann J.
    Br J Pharmacol; 1988 Jan; 93(1):151-5. PubMed ID: 2894873
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Permissive role of dopamine in renal action of ANP in volume-expanded rats.
    Katoh T, Sophasan S, Kurokawa K.
    Am J Physiol; 1989 Aug; 257(2 Pt 2):F300-9. PubMed ID: 2527470
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Up-regulation of renal adenylate cyclase-coupled vasopressin receptors after chronic administration of vasopressin antagonists to rats.
    Caltabiano S, Kinter LB.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1046-54. PubMed ID: 1832462
    [Abstract] [Full Text] [Related]

  • 9. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF.
    Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089
    [Abstract] [Full Text] [Related]

  • 10. Central effects of dopamine on vasopressin release in the normally hydrated and water-loaded rat.
    Forsling ML, Williams H.
    J Physiol; 1984 Jan; 346():49-59. PubMed ID: 6699783
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renal response to arginine vasopressin during the oestrous cycle in the rat: comparison of glucose and saline infusion using physiological doses of vasopressin.
    Hartley DE, Forsling ML.
    Exp Physiol; 2002 Jan; 87(1):9-15. PubMed ID: 11805852
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modification of avoidance responding by amphetamine and dopamine receptor antagonists.
    Jakubowska-Doğru E.
    Pol J Pharmacol; 1999 Jan; 51(4):301-9. PubMed ID: 10540961
    [Abstract] [Full Text] [Related]

  • 20. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
    Imperato A, Obinu MC, Casu MA, Mascia MS, Dazzi L, Gessa GL.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.